Suchen Sie nach Informationen zu Mallinckrodt Unternehmenszentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
http://www.mallinckrodt.com/
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Resources For:
https://www.mallinckrodt.com/about/news-and-media/news-detail/?id=29021
DUBLIN, June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ) ("Mallinckrodt" or the "Company") today announced that it expects to complete its reorganization process, emerge from Chapter 11 and complete the Irish Examinership proceedings in the coming days.. On the effective date of emergence, all of Mallinckrodt's existing ordinary shares will be …
https://www.mallinckrodt.com/about/news-and-media/news-detail/?id=29031
Appoints Sigurdur Olafsson as President and Chief Executive Officer. DUBLIN, Ireland, June 16, 2022 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company") today announced that it has successfully completed its reorganization process, emerged from Chapter 11 and completed the Irish Examinership proceedings.. The Company is moving forward as a …
https://mallinckrodt.com/investors/annual-reports
Title. 2021 Irish Statutory Accounts. 2021 10-K. 2021 Proxy Statement. 2020 10-K/A. 2020 10-K. 2020 Irish Statutory Accounts. 2020 Annual General Meeting. 2020 Proxy Statement Supplement.
https://www.mallinckrodt.com/about/executive-committee/
The Mallinckrodt Pharmaceuticals leadership team is committed to quality, integrity and service — in everything we manufacture, in the business we run, and in our interactions with external stakeholders and each other. Learn more about the people behind our strong foundation and forward-focused vision. Sigurdur (Siggi) Olafsson President and ...
https://markets.businessinsider.com/news/stocks/mallinckrodt-emerges-from-chapter-11-with-strengthened-balance-sheet-and-enhanced-financial-flexibility-1031534359
DUBLIN, Ireland, June 16, 2022 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company") today announced that it has successfully completed its reorganization process, emerged from ...
https://mallinckrodt.com/about/executive-committee/Sigurdur-Olafsson/
Olafsson is also a member of Mallinckrodt’s executive committee and Mallinckrodt’s Board of Directors. Mr. Olafsson has almost 30 years of diverse pharmaceutical experience across branded and generic drugs. Before joining Mallinckrodt, Mr. Olafsson served as CEO of Hikma Pharmaceuticals. Prior to Hikma, Mr. Olafsson served as President and ...
http://www.mallinckrodtsecuritieslitigation.com/
If you purchased or otherwise acquired Mallinckrodt plc. common stock from 10/6/2015, through 11/6/2017, you may be entitled to a payment from a settlement. Mallinckrodt Securities Litigation By providing your information, either on paper, electronically or through a website, you consent to us storing and using your information for case ...
https://restructuring.ra.kroll.com/mallinckrodt/
Additional information, including press releases and FAQs, is available at www.advancingmnk.com. For all supplier-related inquiries, please call the Company toll-free in the U.S. at 1-833-954-2209 or 1-314-654-3008 for international calls, or email the Company at [email protected].
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Mallinckrodt Unternehmenszentrale gefunden haben.
